{"DataElement":{"publicId":"8035862","version":"1","preferredName":"Creatinine Alanine Aminotransferase Bilirubin Laboratory Test Result Greater Than or Equal To Moderate Adverse Event Present Indicator","preferredDefinition":"Indicator of whether creatinine, alanine aminotransferase, or bilirubin laboratory test results were greater than or equal to a moderate adverse event was present.","longName":"LIVER_KIDNEY_TESTS_MOD_AE_IND","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"8035860","version":"1","preferredName":"Creatinine Alanine Aminotransferase Bilirubin Laboratory Test Result Greater Than or Equal To Moderate Adverse Event Present","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways._An experience that is alleviated with simple therapeutic treatments. The event impacts usual daily activities. Includes laboratory test alterations indicating injury, but without long-term risk._Being or existing in a specified place or at the specified time._The outcome of a laboratory test._The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function._A family of pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis. Alanine aminotransferase specifically and reversibly catalyzes the transfer of an amino group from L-alanine to alpha-ketoglutarate forming pyruvate and L-glutamate._A dark orange, yellow pigment that is the product of the breakdown of iron in the blood; it is conjugated in the liver and excreted in the bile.","longName":"8035858v1.0:8035847v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"8035858","version":"1","preferredName":"Creatinine Alanine Aminotransferase Bilirubin Laboratory Test Result","preferredDefinition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.:A family of pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis. Alanine aminotransferase specifically and reversibly catalyzes the transfer of an amino group from L-alanine to alpha-ketoglutarate forming pyruvate and L-glutamate.:A bile pigment that is a degradation product of HEME.:The outcome of a laboratory test.","longName":"C399:C25293:C305:C36292","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Creatinine","conceptCode":"C399","definition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Alanine Aminotransferase","conceptCode":"C25293","definition":"A family of pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis. Alanine aminotransferase specifically and reversibly catalyzes the transfer of an amino group from L-alanine to alpha-ketoglutarate forming pyruvate and L-glutamate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Bilirubin","conceptCode":"C305","definition":"A dark orange, yellow pigment that is the product of the breakdown of iron in the blood; it is conjugated in the liver and excreted in the bile.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Test Result","conceptCode":"C36292","definition":"The outcome of a laboratory test.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7A21C67-A629-0D1D-E053-4EBD850A5092","latestVersionIndicator":"Yes","beginDate":"2022-02-09","endDate":null,"createdBy":"LISU","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"8035847","version":"1","preferredName":"Greater Than or Equal To Moderate Adverse Event Present","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.:An experience that is alleviated with simple therapeutic treatments. The event impacts usual daily activities. Includes laboratory test alterations indicating injury, but without long-term risk.:Being or existing in a specified place or at the specified time.","longName":"C61583:C41339:C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Moderate Adverse Event","conceptCode":"C41339","definition":"An experience that is alleviated with simple therapeutic treatments. The event impacts usual daily activities. Includes laboratory test alterations indicating injury, but without long-term risk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7A17252-E2AE-4D0D-E053-4EBD850A8EBD","latestVersionIndicator":"Yes","beginDate":"2022-02-09","endDate":null,"createdBy":"LISU","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7A21C67-A637-0D1D-E053-4EBD850A5092","latestVersionIndicator":"Yes","beginDate":"2022-02-09","endDate":null,"createdBy":"LISU","dateCreated":"2022-02-09","modifiedBy":"KUMMEROA","dateModified":"2022-10-05","changeDescription":"2/9/2022 created for ANBL1531 study  SL","administrativeNotes":"2022.10.5 Reviewed and released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6230593","version":"1","preferredName":"Yes No Not Assessed Indicator","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"6230593v1.0","context":"CCTG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not assessed","valueDescription":"NOT ASSESSED","ValueMeaning":{"publicId":"2559594","version":"1","preferredName":"NOT ASSESSED","longName":"2559594","preferredDefinition":"Indicates that an assessment was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Assessed","conceptCode":"C139527","definition":"Indicates that an assessment was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5D7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AC3263C-1CBC-4142-E053-F662850AEE6D","beginDate":"2018-04-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-26","modifiedBy":"ONEDATA","dateModified":"2018-04-26","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AC3263C-1CC6-4142-E053-F662850AEE6D","beginDate":"2018-04-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-26","modifiedBy":"ONEDATA","dateModified":"2018-04-26","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"5676138","version":"1","preferredName":"Yes","longName":"5676138","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49204933-EF64-01C8-E053-F662850A7582","latestVersionIndicator":"Yes","beginDate":"2017-02-22","endDate":null,"createdBy":"ANDERSONR","dateCreated":"2017-02-22","modifiedBy":"MMADDINENI","dateModified":"2024-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AC3263C-1CD0-4142-E053-F662850AEE6D","beginDate":"2018-04-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-26","modifiedBy":"ONEDATA","dateModified":"2018-04-26","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9A1583A-1E4D-5229-E053-731AD00A92E9","beginDate":"2023-04-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-18","modifiedBy":"SOKKERL","dateModified":"2023-04-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2320047","version":"1","preferredName":"Indicator","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FC6EF0D8-521A-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6AC3263C-1CA5-4142-E053-F662850AEE6D","latestVersionIndicator":"Yes","beginDate":"2018-04-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-26","modifiedBy":"SOKKERL","dateModified":"2023-04-18","changeDescription":"11/26/18 TT released/CWinch. 4/26/18 tt/MA 39 Death Report","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Was creatinine, alanine aminotransferase, or bilirubin laboratory test results greater than or equal to a moderate adverse event present?","url":null,"context":"COG"},{"name":"COG-TEXT-1","type":"Alternate Question Text","description":"Did patient have creatinine greater than or equal to 1.5 x upper limit of normal for sex and current age or Grade 2 or higher ALT or bilirubin during this reporting period?","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Did patient have moderate adverse event or high in creatinine, ALT or bilirubin laboratory tests during this reporting period?","url":null,"context":"COG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Did the patient have any grade alanine aminotransferase (ALT) elevation during this Maintenance cycle?","url":null,"context":"COG"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Did the patient have any grade bilirubin elevation during this Maintenance cycle?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7A224A4-51DC-4CCD-E053-4EBD850AADEA","latestVersionIndicator":"Yes","beginDate":"2022-02-09","endDate":null,"createdBy":"LISU","dateCreated":"2022-02-09","modifiedBy":"KUMMEROA","dateModified":"2023-11-17","changeDescription":"2/9/2022 created for ANBL1531 study  SL","administrativeNotes":"2023.11.17 AQT added per ticket request CADSR0003092. ak 2022.10.5 Reviewed, cleaned up and released. ak","unresolvedIssues":null,"deletedIndicator":"No"}}